NCT06889493
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06889493
Title SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Peter Hosein, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Miami RECRUITING Miami Florida 33136 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field